4 things to know about the Novavax vaccine
In the fight against COVID-19, vaccines represent a crucial defense against the virus. The Novavax vaccine, among others, has garnered significant attention for its potential to contribute to the global vaccination effort. Gaining insight into its working, eligibility and status will help individuals make informed decisions in consultation with healthcare professionals. Here are four pertinent points to help better understand the vaccine and how it works. Is the Novavax Vaccine Authorized? The Novavax vaccine is available under emergency use authorization (EUA) to prevent COVID-19 in individuals 12 years of age and older. How Does Novavax Vaccine Work? The vaccine employs a conventional virus-blocking technique where the nanoparticulate does not have any genetic material, ensuring it cannot cause illness. Here is how it works: Introduction of Spike Protein : When one gets the Novavax vaccine, one’s body receives the spike protein, which is like a harmless piece of the COVID-19 virus. Immune Response : One’s immune system sees this spike protein as an intruder and produces antibodies and T-cells to fight the perceived threat. Memory : Importantly, the immune system “remembers” how to fight this spike protein. So, if one encounters the actual virus in the future, one’s immune system can swiftly eliminate the threat.
Read More